Form 4: Lexicon Pharmaceuticals VP Kristen Alexander Reports Stock Transactions
SEC Form 4 Filing
Kristen Alexander, VP of Finance and Accounting at Lexicon Pharmaceuticals, reports the vesting and subsequent disposal of restricted stock units to cover tax obligations.
Summary
- On February 28, 2025, Kristen Alexander, VP of Finance and Accounting at Lexicon Pharmaceuticals, engaged in transactions involving restricted stock units.
- Alexander vested 10,617, 15,926, and 19,887 restricted stock units, each representing a contingent right to receive one share of common stock.
- Following the vesting, a total of 17,862 shares were withheld by the company at a price of $0.67 per share to satisfy tax withholding obligations.
- After these transactions, Alexander directly owns 76,368 shares of Lexicon Pharmaceuticals common stock.
- Alexander also holds 0, 15,927, and 39,773 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing reflecting standard compensation practices; it doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of compliance for corporate insiders, providing transparency into their trading activities and ownership positions in their companies. This filing indicates standard compensation practices involving stock-based awards.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of transactions involving restricted stock units and common stock. |
| 03/03/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.